1. Akiyama, M., Kaneko, Y. & Takeuchi, T. (2020) Tocilizumab in isolated polymyalgia rheumatica: a systematic literature review. Semin. Arthritis Rheum., doi: 10.1016/j.semarthrit.2019.12.005. [Epub ahead of print].
2. Aletaha, D., Neogi, T., Silman, A.J., Funovits, J., Felson, D.T., Bingham, C.O. 3rd, Birnbaum, N.S., Burmester, G.R., Bykerk, V.P., Cohen, M.D., Combe, B., Costenbader, K.H., Dougados, M., Emery, P., Ferraccioli, G., et al. (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann. Rheum. Dis., 69, 1580-1588.
3. Behn, A.R., Perera, T. & Myles, A.B. (1983) Polymyalgia rheumatica and corticosteroids: how much for how long? Ann. Rheum. Dis., 42, 374-378.
4. Bird, H.A., Esselinckx, W., Dixon, A.S., Mowat, A.G. & Wood, P.H. (1979) An evaluation of criteria for polymyalgia rheumatica. Ann. Rheum. Dis., 38, 434-439.
5. Brooks, R.C. & McGee, S.R. (1997) Diagnostic dilemmas in polymyalgia rheumatica. Arch. Intern. Med., 157, 162-168.